1. Home
  2. CVGI vs PRLD Comparison

CVGI vs PRLD Comparison

Compare CVGI & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commercial Vehicle Group Inc.

CVGI

Commercial Vehicle Group Inc.

HOLD

Current Price

$2.90

Market Cap

59.5M

ML Signal

HOLD

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$3.30

Market Cap

69.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVGI
PRLD
Founded
2000
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.5M
69.1M
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
CVGI
PRLD
Price
$2.90
$3.30
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.67
AVG Volume (30 Days)
873.1K
318.9K
Earning Date
06-15-2026
06-17-2026
Dividend Yield
N/A
N/A
EPS Growth
316.18
23.21
EPS
0.04
N/A
Revenue
$755,231,000.00
$12,140,000.00
Revenue This Year
N/A
$320.10
Revenue Next Year
$8.47
$100.00
P/E Ratio
$58.25
N/A
Revenue Growth
14.06
73.43
52 Week Low
$0.81
$0.61
52 Week High
$2.62
$4.19

Technical Indicators

Market Signals
Indicator
CVGI
PRLD
Relative Strength Index (RSI) 78.78 60.16
Support Level $1.49 $0.99
Resistance Level N/A $4.19
Average True Range (ATR) 0.21 0.36
MACD 0.10 0.05
Stochastic Oscillator 100.00 54.79

Price Performance

Historical Comparison
CVGI
PRLD

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc is a provider of systems, assemblies, and components to the commercial vehicle market and the electric vehicle markets. It delivers solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities. Its operating segments are Vehicle Solutions, Electrical Systems, and Aftermarket and Accessories. The company makes the majority of its revenue from Vehicle Solutions. The group generates revenue from its products including seating systems, plastic components, electrical wire harnesses, mirrors, wipers, and other accessories. Its geographic regions are North America, Europe and Asia-Pacific.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

Share on Social Networks: